This clinical trial tests whether wearing the Apollo device, a watch-like device that stimulates nerves with wave-like vibrations, helps reduce fatigue in patients with metastatic breast cancer. The Apollo device sends wave-like vibrations to activate nerves in the skin that are sensitive to touch. The nerves send a signal to the brain which can result in decreased stress, improved recovery, focus, and energy.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04983342.
Locations matching your search criteria
United States
Pennsylvania
Pittsburgh
University of Pittsburgh Cancer Institute (UPCI)Status: Active
Contact: Margaret Rosenzweig
Phone: 412-383-8839
PRIMARY OBJECTIVE:
I. To provide preliminary data on the efficacy and tolerability of the Apollo device in the management of fatigue in metastatic breast cancer (MBC).
SECONDARY OBJECTIVES:
I. To provide preliminary data on indices of pain.
II. To provide preliminary data on use of as needed (PRN) pain medications.
III. To provide preliminary data on health-related quality of life, sleep, anxiety and depression.
IV. To provide preliminary data on tolerability/frequency of use with the Apollo device in MBC.
OUTLINE:
Patients wear the Apollo device for 8 weeks.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUniversity of Pittsburgh Cancer Institute (UPCI)
Principal InvestigatorMargaret Rosenzweig
